Ignite Creation Date:
2024-05-05 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00136396
Status:
COMPLETED
Last Update Posted:
2013-06-12
First Post:
2005-08-26
Brief Title:
Rituximab Therapy for Steroid-Refractory Chronic Graft Versus Host Disease
Sponsor:
Dana-Farber Cancer Institute
Organization:
Dana-Farber Cancer Institute